dexiglofozin5mg30tab

Dexiglofozin is a pharmaceutical product containing Dapagliflozin, which belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is primarily indicated for the management of type 2 diabetes mellitus in adults. By inhibiting the SGLT2 protein in the kidneys, it prevents the reabsorption of glucose into the bloodstream, promoting its excretion through urine. This mechanism helps in lowering blood glucose levels and may also provide cardiovascular and renal benefits. It is intended for use alongside diet and exercise to improve glycemic control.